1 Min Read
* ANNOUNCES POSITIVE RESULTS FROM AN EVALUATION OF GARDPROTEIN
* SAYS GARDPROTEIN HAS POTENTIAL TO OPEN UP A NEW MARKET FOR SENZAGEN’S TEST PLATFORM. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.